Introduction
============

Advanced chronic kidney disease often results in adverse cardiovascular outcomes, often the leading causes of mortality in patients with end-stage renal disease (ESRD) [@B1]. ESRD patients on dialysis not only experience traditional cardiovascular risk factors, including hypertension, diabetes, and hyperlipidemia, but also hemodynamic overload and non-hemodynamic risk factors, such as biochemical and neurohormonal factors that promote chronic inflammation and fibrosis [@B2],[@B3].

Cardiac alterations in morphology and function, such as left ventricle (LV) hypertrophy, LV dilation, and systolic dysfunction, are predictors for uremic cardiomyopathy, which results in a 3-fold increased risk of heart failure [@B2],[@B4]. With improved surgical techniques and immunosuppressive regimens, kidney transplantation is now considered the standard therapy to treat ESRD patients. Reports have shown that kidney transplantation normalizes cardiac alterations and leads to corresponding survival improvement in kidney transplant recipients with preoperative cardiac dysfunction. However, changes in diastolic dysfunction after transplantation are somewhat controversial in the literature [@B5]-[@B7], as they may persist or worsen even after transplantation [@B6],[@B8].

Among echocardiographic abnormalities, LV hypertrophy, which is frequently accompanied by cardiac fibrosis and subclinical diastolic dysfunction, develops early during chronic kidney disease progression [@B9]-[@B11]. In early ESRD, diastolic dysfunction with relatively preserved systolic function occurs in more than half of hemodialysis patients as revealed by tissue Doppler echocardiographic assessment [@B12],[@B13]. Several studies have shown that diastolic dysfunction is associated with perioperative cardiopulmonary events in patients undergoing various types of surgery [@B11],[@B14]-[@B16]. The ratio of early transmitral flow velocity to early diastolic velocity of the mitral annulus (E/E\') is a reliable indicator of diastolic function that correlates well with LV filling pressure [@B17]. Even in ESRD patients on hemodialysis, the E/E\' ratio can predict general and cardiac mortality because it is a relatively preload-independent parameter [@B18],[@B19]. In recent years, preemptive or well-timed living donor kidney transplantation has been performed at higher levels of estimated glomerular filtration rate or in earlier stages of dialysis than it was previously, leading to a survival advantage [@B20]. It has not been thoroughly evaluated whether echocardiographic parameters, including reliable indicators of diastolic function, can predict cardiopulmonary complications after kidney transplantation in patients in early dialysis. Therefore, we aimed to analyze the implications of echocardiographic parameters and diastolic dysfunction on major postoperative cardiovascular complications and pulmonary edema in ESRD patients undergoing living donor kidney transplantation.

Patients and Methods
====================

Study participants
------------------

This prospective and observational study was conducted between January 2012 and September 2015 at Yonsei university hospital. After approval from the Institutional Review Board, we registered the study with <http://clinicaltrials.gov> (NCT02322567). We enrolled patients with valid preoperative transthoracic echocardiographic evaluation within 2 months before surgery, aged 20-70 years, classified as American Society of Anesthesiologists Physical Status 3 or 4, and scheduled to undergo living donor kidney transplantation. Patients with severe valvular dysfunction [@B21], history of myocardial infarction, more than minimal pericardial effusion, non-sinus rhythm, previous kidney transplantation, and multiple organ transplantation were excluded.

Assessment of cardiac structure and function
--------------------------------------------

Before surgery, each patient underwent routine transthoracic echocardiography to obtain tissue Doppler measurements the day after the patients\' regular hemodialysis schedule. We calculated their LV ejection fraction with the biplane Simpson method and measured their interventricular septal diameter, LV end-diastolic diameter (LVEDd), LV mass, and posterior wall diameter according to American Society of Echocardiography guidelines [@B22]. We measured LV diastolic function using the ratio of peak early and late (atrial) mitral inflow (E/A) and the E/E\' ratio with echocardiography [@B16],[@B23]. We estimated right ventricular systolic pressure (RVSP) from the tricuspid regurgitation velocity using the modified Bernoulli equation.

Anesthetic management
---------------------

Anesthesia was induced with propofol 1.5-2 mg/kg, remifentanil 0.5-1 μg/kg, and rocuronium bromide 0.6 mg/kg. Subsequently, a radial artery catheter and an internal jugular central venous catheter were inserted. Anesthesia was maintained with desflurane 0.8-1.0 minimal alveolar concentration in 50% O~2~/air mixture and remifentanil 0.05-0.15 μg/kg/min. Acetate-buffered balanced crystalloid solution and total 750 mL of 5% albumin were given throughout the surgery. Any hypotensive episodes (greater than 20% decrease in mean blood pressure (MBP) from the preoperative baseline value) were treated with 6 mg of IV ephedrine and/or norepinephrine infusion. Irradiated filtered packed red blood cells were transfused when the hematocrit level dropped more than 25% from baseline throughout the study period. The operation was performed in a standardized manner in all patients. Intraoperative hemodynamic parameters, including the MBP, heart rate (HR), central venous pressure (CVP), and stroke volume variation (SVV), were recorded at four different time points: 10 min after induction of anesthesia (baseline), 60 minutes after the start of surgery, 10 minutes after reperfusion of the kidney graft, and at the end of surgery. Arterial blood gas (ABG) analyses were performed at the same time points. We also noted the duration of surgery, kidney graft ischemia-reperfusion time, intraoperative fluid balance, and the number of patients receiving any inotropic or vasopressors. Demographic, clinical, echocardiographic, and laboratory data were obtained directly from each patient\'s electronic medical record. All transplant recipients received protocol-driven, standardized immunosuppressive strategies.

Outcome Measures
----------------

The occurrence of in-hospital major cardiovascular complications after kidney transplantation was the primary endpoint of our study, which included acute myocardial infarction, ventricular fibrillation/tachycardia, cardiogenic shock, and newly-onset atrial fibrillation, as well as clinical pulmonary edema requiring endotracheal intubation or dialysis [@B9],[@B24],[@B25]. The secondary endpoint was the development of postoperative pulmonary edema as indicated by radiological evidence during hospitalization, which was evaluated by a designated radiologist blinded to clinical and echocardiographic information from each patient. Serial electrocardiograms and chest radiographs were obtained before surgery, the first and/or second postoperative day, and whenever patients complained of any cardiopulmonary symptoms. We noted any event of delayed graft function (DGF), acute rejection episodes (ARE), and graft loss defined as follows: DGF resulted in dialysis within 1 week of transplantation, ARE included both biopsy-proven and clinically suspected acute rejection until the time of hospital discharge, and graft loss involved initiation of long-term dialysis therapy within 1 year after transplantation [@B26]. We evaluated postoperative kidney function based on serum levels of blood urea nitrogen and creatinine (Cr), and estimated glomerular filtration rate (eGFR) based on the modification of diet in renal disease formula applied on postoperative days 1, 2, and 7.

Statistical analysis
--------------------

We performed statistical analyses using SPSS for Windows, version 20.0 (SPSS Inc, Chicago, IL). All data are expressed as means ± standard deviation (SD), medians (interquartile range), or number of patients (percentage). We compared normally distributed continuous variables using an unpaired two-tailed Student\'s t-test and non-normal continuous variables using a Mann-Whitney *U*-test or Kruskal-Wallis test. We analyzed categorical data with a χ^2^ or Fisher\'s exact test where appropriate. We evaluated repeated measured variables, such as ABG values and postoperative renal function, using linear mixed models with Bonferroni correction. We performed univariate logistic regression analysis to calculate odds ratios for independent parameters associated with in-hospital major cardiovascular complications and postoperative pulmonary edema, and significant variables with *P*-value \< 0.05 were included in the subsequent multivariate logistic regression model. We then calculated the receiver-operating characteristic (ROC) curve to determine the most appropriate E/E\' ratio cut-off value for occurrence of in-hospital major cardiovascular complications and evaluated its accuracy based on the area under the curve (AUC) using MedCalc version 9.3.6.0 (MedCalc Software, Belgium). A *P*-value less than 0.05 indicated statistical significance.

Results
=======

Of the 597 adult patients who underwent living donor kidney transplantation during our study period, we identified 242 patients who fulfilled the inclusion and exclusion criteria. The participants\' demographic and baseline clinical data, including preoperative transthoracic echocardiographic findings, are summarized in Table [1](#T1){ref-type="table"}.

Hypertension was the predominant etiology (36%) of ESRD, followed by glomerulonephritis (21%), however majority of patients had no pre-transplantation biopsy for definite diagnosis (Table [2](#T2){ref-type="table"}). Thirty-nine patients (16%) developed postoperative pulmonary edema, and 9 patients (4%) developed an in-hospital major cardiovascular complication. Specifically, these 9 patients experienced clinical pulmonary edema requiring endotracheal intubation or dialysis (n=4), new-onset atrial fibrillation (n=2), myocardial infarction (n=2), or ventricular fibrillation (n=1).

Intraoperative hemodynamics including MBP, CVP, and SVV; duration of surgery; intraoperative in-out fluid balances; and the number of patients receiving vasopressors during surgery were not significantly different between patients with respect to pulmonary edema or in-hospital major cardiovascular complication occurrence (data was not shown). ABG analysis also revealed no significant difference in pH or PaCO~2~ regarding pulmonary edema or cardiovascular complications, although we noted higher PaO~2~ levels in patients without pulmonary edema than in those with pulmonary edema 60 minutes after the start of surgery (T1) and at 10 minutes after kidney graft reperfusion (T2) (Fig [1](#F1){ref-type="fig"}).

After univariate analysis, we found that patients with in-hospital major cardiovascular complications had prolonged ischemia-reperfusion times during surgery, more frequent diabetes, elevated LVEDd, and greater LVMI, RVSP, LAVI, and E/E\' ratios compared to patients without any of those complications. Multivariate analysis for these risk factors identified the E/E\' ratio as a persistently strong independent predictor for in-hospital major cardiovascular complications (Table [3](#T3){ref-type="table"}). The AUC of the E/E\' ratio was 0.84 (95% CI: 0.787-0.884), and ROC analysis showed the optimal E/E\' cut-off value for predicting major cardiovascular complication was 13.0 with 77.8% sensitivity and 78.5% specificity (Fig [2](#F2){ref-type="fig"}).

Univariate analysis of demographic and echocardiographic data identified age, LVEDd, LVMI, LAVI, and E/E\' ratios as risk factors for postoperative pulmonary edema (Table [4](#T4){ref-type="table"}). However, we observed no significant differences with respect to other patient characteristics, including dialysis modalities, duration of renal replacement therapy prior to transplantation, and years diagnosed with chronic renal failure (Table [4](#T4){ref-type="table"}). After subsequent multivariate analysis, no parameter remained statistically significant.

Postoperative renal function significantly increased, as indicated by serum Cr on postoperative day 7, in the major cardiovascular complication group compared to patients without complications. Levels of eGFR increased significantly during postoperative day 7 in patients without major cardiovascular complications or pulmonary edema, while the amount of daily urine output was not significantly different with respect to postoperative cardiovascular complications or pulmonary outcome (Fig [3](#F3){ref-type="fig"}). Greater percentages of patients with major cardiovascular complications were associated with DGF, ARF or graft loss altogether, compared to patients without such complications (Table [5](#T5){ref-type="table"}). We also noted a significant difference in mean length of hospital stay according to the development of pulmonary edema (*P* = 0.033) but not occurrence of in-hospital major cardiovascular complications (Table [5](#T5){ref-type="table"}). One in-hospital mortality occurred after transplantation during the study period, in which the patient died from multi-organ failure on postoperative day 74.

Discussions
===========

We evaluated the utility of echocardiographic parameters for predicting postoperative cardiopulmonary events in patients undergoing living donor kidney transplantation. We found that a greater preoperative E/E\' ratio, a reliable indicator of LV diastolic dysfunction, was significantly related to the development of major cardiovascular complications in kidney recipients during a defined postoperative period.

Cardiac structure and function alterations in patients with chronic kidney disease have been extensively studied, leading to a growing appreciation of the impact of cardiovascular abnormalities on morbidity and mortality in ESRD patients [@B1],[@B5],[@B27]. The pathophysiological characteristics of these abnormalities in chronic kidney disease and ESRD involve hemodynamic overload from arteriovenous shunts, arterial remodeling, and anemia, as well as metabolic changes, such as uremic toxicity, renin-angiotensin-aldosterone system hyperactivity, and secondary hyperparathyroidism [@B2]-[@B4]. Through these diverse mechanisms, even during early progressive chronic kidney disease, myocardial hypertrophy and fibrosis lead to alterations in LV relaxation and compliance and ultimately to the development of LV diastolic dysfunction [@B13]. The prevalence of this dysfunction evaluated by echocardiography in ESRD patients ranges from 30-75%, depending on the criteria used for its quantification [@B6],[@B9],[@B13]. Furthermore, LV hypertrophy and shifted LV pressure-volume curves exacerbate the effects of both blood volume changes on LV filling pressure and arrhythmia on hemodynamic instability [@B28]. The prognostic impact of diastolic dysfunction on clinical morbidities, such as pulmonary edema, major cardiovascular complications, or even death, has been demonstrated in various populations of patients [@B12],[@B16]. Fifty percent of ESRD patients in their first year of hemodialysis experienced mild diastolic dysfunction, and 23% of patients presented with pseudo normalization or restrictive flow pattern predictive of cardiovascular events (hazard ratio 2.2), regardless of age, gender, diabetes, LV mass, or ejection fraction [@B13]. However, limited information exists regarding the relationship between diastolic dysfunction and cardiopulmonary complications in ESRD patients undergoing kidney transplantation. Thus, we evaluated the impact of preoperative diastolic dysfunction on the occurrence of major cardiovascular complications and postoperative pulmonary edema in ESRD patients after living donor kidney transplantation using tissue Doppler imaging.

Among various relevant echocardiographic parameters, the role of tissue Doppler echocardiography in predicting diastolic dysfunction has been explored previously [@B29],[@B30]. Specifically, the E/E\' ratio is a relatively independent preload parameter that correlates with LV filling pressure [@B19] and predicts certain cardiovascular outcomes, such as cardiomyopathy, acute myocardial infarction, and atrial fibrillation [@B14],[@B15],[@B29]. For example, an E/E\' ratio of \<8 or \>15 accurately predicts normal or increased mean LV diastolic pressure, respectively, whereas an E/E\' ratio between 8 and 15 shows poor correlation [@B17],[@B31],[@B32]. Additionally, an E/E\' ratio greater than 15 reliably predicts mortality [@B19],[@B33]. In previous studies evaluating the cardiovascular effects of successful kidney transplantation, LV hypertrophy and systolic dysfunction resolved after transplantation, but data regarding the impact of transplant toward diastolic dysfunction are controversial [@B5]-[@B7]. Interestingly, analyses limited to use of transmitral flow-derived Doppler parameters identified progressive LV diastolic dysfunction, despite improvement of systolic function and LV hypertrophy after successful transplantation [@B6],[@B8]. In contrast, studies assessing diastolic function in terms of E/E\' ratio have shown improved diastolic function in concordance with alterations in systolic function and LV mass [@B5],[@B7]. In this context, our current study determined that prolonged ischemia-reperfusion time, diagnosis of diabetes, elevated LVEDd, and greater LVMI, RVSP, LAVI, and E/E\' ratio were significant risk factors for in-hospital major cardiovascular complications, with E/E\' ratio strongly correlating with the development of adverse cardiovascular complications after multivariate analysis. Moreover, ROC analysis identified 13.0 as the optimal cut-off value of the E/E\' ratio for predicting major cardiovascular complications with an accompanying AUC of 0.84, which corroborates previous reports that found an E/E\' ratio greater than 15 closely relates to patient morbidities.

Achieving optimal fluid management therapy for ESRD patients undergoing kidney transplantation is critical for maintaining adequate intravascular volume to enhance graft function and avoid fluid overload [@B34],[@B35], especially because the transplanted kidney is denervated and lacks autoregulation [@B36]. Deleterious effects of fluid overload on cardiovascular and pulmonary physiology include impaired cardiac output and related morbidities, so various attempts to establish a standard management strategy during and after kidney transplantation have been made. The most commonly adopted management principle is CVP due to its ability to indirectly reflect a patient\'s volume status, although goal-direct fluid therapy targets SVV to guide fluid management and may be superior to traditional CVP monitoring [@B37]. However, we found that patients showed changes in MBP, HR, CVP, and SVV during the perioperative period, regardless of postoperative pulmonary edema and major cardiovascular complication occurrence, highlighting the limitations of hemodynamic parameters to predict and prevent the development of post-transplant cardiopulmonary complications. Echocardiography, a highly precise tool for evaluating volume status during various types of surgery, is a more reliable predictor of such complications compared to the hemodynamic parameters mentioned above. As the importance of echocardiography in fluid management continues to be emphasized, more comprehensive preoperative cardiac work-ups for every transplant candidate should be performed to provide an individualized strategy for proper goal-directed therapy.

We also identified age, LVEDd, LVMI, LAVI, and E/E\' ratio as risk factors for postoperative pulmonary edema. Unexpectedly, pulmonary edema diagnosed with postoperative chest x-rays only weakly correlated with preoperative echocardiographic parameters and postoperative prognosis, such as DGF, ARE, and graft loss. In contrast, in-hospital major cardiovascular complications, including clinical pulmonary edema requiring endotracheal intubation or dialysis, strongly correlated with certain diastolic dysfunction-related echocardiographic parameters and postoperative deterioration of graft function. Such correlations can be inferred from the inevitable causal relationship between overloaded volume status of ESRD patients and their diastolic dysfunction, which can worsen volume overload and result in unfavorable cardiorespiratory and graft outcomes. Study patients who developed perioperative pulmonary edema also exhibited characteristic ABG findings consistent with pulmonary edema, such as low PaO~2~, even when baseline oxygenation levels were not significantly different.

One limitation of the current study is its observational nature, which may promote study bias. This study only included patients selected for living donor kidney transplantation with well-qualified 2-months preoperative echocardiographic data during the study period, which might have influenced the prognostic conclusions that could be drawn from our analysis. Moreover, we could not control for the timing of preoperative echocardiograms, so possible variations in intravascular volume may have affected the echocardiographic data of ESRD patients on hemodialysis. In addition, our study population may not be consistent demographically and/or clinically with patients from previous studies with respect to progression of LV systolic dysfunction. In this study, only one patient experienced moderate LV systolic dysfunction, and none presented with severe LV systolic dysfunction per preoperative echocardiography. Thus, our emphasis on diastolic, rather than systolic, dysfunction may be contrary to findings from previous studies, which focused on the prognostic value of systolic dysfunction after kidney transplantation [@B5],[@B38]. The patients enrolled in our study were relatively younger compared to those of previous studies, as most of our patients were scheduled for preemptive kidney transplantation before full-blown kidney failure. Such different biased distribution of patient age may have been the reason for the unique patient presentation in the present study, which could have affected the absence of age-related contributions on postoperative complications. Lastly, we followed patient prognosis during the initial post-transplant hospital stay only, which can be relatively short, while other studies incorporated long-term evaluation periods for graft outcomes and patient prognosis.

In conclusion, subclinical LV diastolic dysfunction as indicated by a high E/E\' ratio can consistently predict the occurrence of in-hospital major cardiovascular complications in living donor kidney recipients. Based on our results, we propose that ESRD patients with preexisting subclinical diastolic dysfunction who will undergo living donor kidney transplantation be carefully monitored for volume and hemodynamic imbalances during the perioperative period.
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![Comparison of changes in arterial oxygen pressure during kidney transplantation surgery regarding development of postoperative (a) pulmonary edema and no pulmonary edema or (b) major cardiovascular complications and no cardiovascular complications. pO2, arterial oxygen pressure; non-PE, no postoperative pulmonary edema; PE, postoperative pulmonary edema; non-CV, no major postoperative cardiovascular complications; CV, major postoperative cardiovascular complications; T0, before surgery (baseline); T1, 60 minutes after surgery; T2, 10 minutes after kidney graft reperfusion; T3, end of surgery. \*P \< 0.05 compared to the PE group.](ijmsv13p0620g001){#F1}

![Receiver-operating characteristic (ROC) curve for the E/E\' ratio\'s prediction of postoperative major cardiovascular complications. The ROC area under the ROC curve was 0.84 (95% confidence interval: 0.787-0.884; *P* \< 0.001).](ijmsv13p0620g002){#F2}
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###### 

Baseline characteristics and Echocardiographic data.

  Age (yr)                   44.7 ± 11.6             
  -------------------------- -------------------- -- --
  Male                       150 (62)                
  BMI (kg/m^2^)              22.2 ± 3.6              
  Medical History                                    
  HTN                        197 (81)                
  DM                         51 (21)                 
  CAOD                       8 (3)                   
  COPD                       3 (1)                   
  HD/PD                      199 (82) / 26 (11)      
  Duration of CRF (yr)       1.5 (0.5-5.3)           
  Duration of RRT (months)   2 (1-14)                
  Preoperative Hb (mg/dL)    10.2 ± 1.5              
  Operative Data                                     
  Op time (min)              268.5 ± 62.9            
  I-R time (min)             71.9 ± 21.4             
  Echocardiographic data                             
  LVEF (%)                   65.0 ± 6.3              
  LVESd (mm)                 33.9 ± 4.4              
  LVEDd (mm)                 50.9 ± 4.7              
  LVMI (g/m^2^)              117.5 ± 32.1            
  LV hypertrophy             78 (32)                 
  E/A ratio ≥ 2              7 (3)                   
  E/E\' ratio                11.0 ± 4.4              
  \> 15                      33 (14)                 
  8-15                       157 (65)                
  \<8                        52 (21)                 
  RVSP (mmHg)                26.2 ± 8.2              
  ≥ 35 mmHg                  22 (9)                  
  LAVI (mL/m^2^)             31.4 ± 11.5             
                                                     

Numbers are expressed as means ± SD, medians (interquartile range), or numbers of patients (percentage).

BMI, body mass index; HD, hemodialysis; PD, peritoneal dialysis; CRF, chronic renal failure; RRT, renal replacement therapy; Hb, hemoglobin; I-R time, ischemia-reperfusion time, LVEF, LV ejection fraction; LVESd, LV end-systolic dimension; LVEDd, LV end-diastolic dimension; LVMI, LV mass index; E/A, ratio of early (E) to late (A) ventricular filling velocities; E/E\' ratio, ratio of mitral peak velocity of early filling (E) to early diastolic mitral annular velocity (E\'); RVSP, right ventricular systolic pressure; LAVI, LA volume index.

###### 

Primary renal disease leading to ESRD.

  Primary disease for ESRD        
  ------------------------------- ---------
  HTN                             88 (36)
  DM                              9 (4)
  GN                              51 (21)
  IgA nephropathy                 43 (18)
  MPGN                            2 (1)
  RPGN                            2 (1)
  Lupus nephritis                 2 (1)
  Immune-mediated GN              2 (1)
  FSGS                            12 (5)
  PKD                             7 (3)
  No pre-transplantation biopsy   76 (31)

Numbers are expressed as numbers of patients (percentage).

ESRD, end-stage renal disease; HTN, hypertension; DM, diabetes mellitus; GN, glomerulonephritis; MPGN, membranoproliferative glomerulonerphritis; RPGN, rapidly progressive glomerulonephritis; FSGS, focal segmental glomerulosclerosis; PKD, polycystic kidney disease.

###### 

Predictors of postoperative in-hospital major cardiovascular complications on univariate and multivariate analyses.

                             Univariate Analysis    Multivariate Analysis                          
  -------------------------- ---------------------- ----------------------- ---------------------- -----------
                             OR (95% CI)            *P*-value               OR (95% CI)            *P*-value
  Baseline Characteristics                                                                         
  Age                        1.052 (0.985-1.124)    0.128                   \-                     
  Male                       2.098 (0.549-8.022)    0.279                   \-                     
  BMI (kg/m^2^)              1.061 (0.879-1.280)    0.539                   \-                     
  Medical History                                                                                  
  HTN                        1.862 (0.227-15.279)   0.562                   \-                     
  DM                         5.082 (1.312-19.676)   0.019                   6.445 (0.651-63.799)   0.111
  CAOD                       4.036 (0.442-36.816)   0.216                   \-                     
  HD vs. PD                  0.342 (0.065-1.798)    0.205                   \-                     
  Duration of CRF (yr)       0.957 (0.826-1.109)    0.561                   \-                     
  Duration of RRT (months)   1.006 (0.993-1.019)    0.382                   \-                     
  Operative Data                                                                                   
  Op time (min)              0.997 (0.984-1.009)    0.599                   \-                     
  I-R time (min)             1.034 (1.010-1.059)    0.006                   1.033 (0.976-1.093)    0.267
  Echocardiographic data                                                                           
  LVEF (%)                   0.958 (0.870-1.055)    0.379                   \-                     
  LVESd (mm)                 1.227 (1.089-1.383)    0.001                   1.114 (0.817-1.519)    0.496
  LVEDd (mm)                 1.282 (1.112-1.477)    0.001                   1.493 (0.878-2.539)    0.139
  LVMI (g/m^2^)              1.025 (1.009-1.041)    0.002                   0.992 (0.959-1.027)    0.666
  E/E\' ratio                1.251 (1.105-1.417)    \<0.001                 1.602 (1.138-2.254)    0.007
  RVSP (mmHg)                1.064 (1.007-1.124)    0.027                   0.918 (0.775-1.088)    0.324
  LAVI (mL/m^2^)             1.059 (1.011-1.110)    0.016                   0.918 (0.793-1.063)    0.255

Numbers are expressed as odds ratio (95% Confidence Interval).

OR, odds ratio; CI, confidence interval; BMI, body mass index; HD, hemodialysis; PD, peritoneal dialysis; CRF, chronic renal failure; RRT, renal replacement therapy; I-R time, ischemia-reperfusion time, LVEF, LV ejection fraction; LVESd, LV end-systolic dimension; LVEDd, LV end-diastolic dimension; LVMI, LV mass index; E/E\' ratio, the ratio of mitral peak velocity of early filling (E) to early diastolic mitral annular velocity (E\'); RVSP, right ventricular systolic pressure; LAVI, LA volume index.

###### 

Predictors of postoperative pulmonary edema on univariate and multivariate analyses.

                             Univariate Analysis   Multivariate Analysis                         
  -------------------------- --------------------- ----------------------- --------------------- -----------
                             OR (95% CI)           *P*-value               OR (95% CI)           *P*-value
  Baseline Characteristics                                                                       
  Age                        1.037 (1.004-1.071)   0.028                   1.029 (0.994-1.066)   0.106
  Male                       1.162 (0.578-2.337)   0.673                   \-                    \-
  BMI (kg/m^2^)              1.102 (0.997-1.218)   0.056                   \-                    \-
  Medical History                                                                                
  HTN                        2.215 (0.745-6.585)   0.153                   \-                    \-
  DM                         1.601 (0.735-3.487)   0.236                   \-                    \-
  CAOD                       1.775 (0.345-9.134)   0.493                   \-                    \-
  HD vs. PD                  1.030 (0.331-3.206)   0.959                   \-                    \-
  Duration of RRT (months)   1.000 (0.991-1.009)   0.941                                         
  Duration of CRF (yr)       0.953 (0.884-1.028)   0.215                   \-                    \-
  Operative Data                                                                                 
  Op time (min)              1.000 (0.995-1.006)   0.977                   \-                    \-
  I-R time (min)             1.001 (0.985-1.017)   0.951                   \-                    \-
  Echocardiographic data                                                                         
  LVEF (%)                   0.995 (0.943-1.051)   0.865                   \-                    \-
  LVESd (mm)                 1.057 (0.982-1.137)   0.141                   \-                    \-
  LVEDd (mm)                 1.087 (1.009-1.171)   0.029                   1.060 (0.963-1.168)   0.233
  LVMI (g/m^2^)              1.012 (1.003-1.022)   0.014                   1.004 (0.990-1.019)   0.574
  E/E\' ratio                1.090 (1.016-1.169)   0.016                   1.041 (0.951-1.141)   0.385
  RVSP (mmHg)                1.034 (0.994-1.075)   0.098                   \-                    \-
  LAVI (mL/m^2^)             1.029 (1.001-1.058)   0.044                   0.996 (0.956-1.038)   0.861

Numbers are expressed as odds ratio (95% Confidence Interval).

OR, odds ratio; CI confidence interval; BMI, body mass index; HD, hemodialysis; PD, peritoneal dialysis; CRF, chronic renal failure; RRT, renal replacement therapy; I-R time, ischemia-reperfusion time, LVEF, LV ejection fraction; LVESd, LV end-systolic dimension; LVEDd, LV end-diastolic dimension; LVMI, LV mass index; E/E\' ratio, the ratio of mitral peak velocity of early filling (E) to early diastolic mitral annular velocity (E\'); RVSP, right ventricular systolic pressure; LAVI, LA volume index.

###### 

Postoperative Outcomes.

                                   In-hospital major cardiovascular complications   Pulmonary edema                                          
  -------------------------------- ------------------------------------------------ ----------------- ----------- ------------- ------------ -----------
                                   Yes (n=9)                                        No (n=233)        *P*-value   Yes (n=39)    No (n=203)   *P*-value
  DGF                              2 (22)                                           10 (4)            0.015       3 (8)         9 (4)        0.392
  ARE                              3 (33)                                           20 (9)            0.013       5 (13)        18 (9)       0.442
  Graft Loss                       1 (11)                                           3 (1)             0.024       2 (5)         2 (1)        0.064
  Length of Hospital Stay (days)   17.0 ± 5.4                                       15.6 ± 5.9        0.477       17.5 ± 10.2   15.3 ± 4.5   0.033

Numbers are expressed as numbers of patients (percentage), or means ± SD.

DGF, delayed graft function; ARE, acute rejection episode.
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